NCT05085808View on ClinicalTrials.gov

RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions
DeliriumMoralityQuality of LifePsychTreatment Side Effects
Interventions
DRUG

Trazodone

Trazodone will be administered to ICU patients who need pharmacological intervention for delirium, if they are randomized to the trazodone arm.

DRUG

Quetiapine

Quetiapine will be administered to ICU patients who need pharmacological intervention for delirium, if they are randomized to the quetiapine arm.

DRUG

Placebo

Placebo will be administered to ICU patients who need pharmacological intervention for delirium, if they are randomized to the placebo arm.

Trial Locations (1)

90033

Keck Hospital of the University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER